Skip to main content

Table 3 Effect of glycerol supplementation and L. reuteri PTA5_F13 on the metabolic activity of chicken cecal microbiota during in vitro F3

From: Glycerol and reuterin-producing Limosilactobacillus reuteri enhance butyrate production and inhibit Enterobacteriaceae in broiler chicken cecal microbiota PolyFermS model

Reactors

Mean metabolite concentration (mM) ± SD

Ratios of Total SCFAs (%)

Acetate

Butyrate

Propionate

Succinate

Valerate

1,3 – PDO

Total BCFAs

Total metabolites

Acetate

Butyrate

Propionate

Control

 Pre-treatment

83.9 ± 1.9

48.7 ± 0.5

11.7 ± 0.6

2.4 ± 1.5

9.7 ± 0.5

0.0 ± 0.0

15.0 ± 0.3

171.1 ± 4.0

58.1 ± 0.2

33.7 ± 0.6

8.1 ± 0.2

 Treatment

76.5 ± 1.1

46.4 ± 0.6

10.7 ± 0.3

1.1 ± 0.1

9.0 ± 0.1

0.0 ± 0.0

16.6 ± 0.2

160.7 ± 1.6

57.2 ± 0.1

34.7 ± 0.3

8.0 ± 0.2

 Treatment – Pre treatment

- 7.4

- 2.2

- 1.0

- 1.3

- 0.6

 

 + 1.6

- 10.8

- 0.8

 + 0.9

0.1

 P value

0.0045

0.0092

0.0609

0.1942

0.0769

 

0.0009

0.0123

0.0091

0.0611

0.6745

100G

 Pre-treatment

95.3 ± 3.0

44.9 ± 1.4

10.3 ± 1.4

0.7 ± 0.1

9.4 ± 0.2

0.0 ± 0.0

14.9 ± 0.4

175.8 ± 6.1

63.3 ± 0.5

29.8 ± 0.2

6.8 ± 0.7

 Treatment

63.2 ± 1.0

83.1 ± 4.1

5.9 ± 0.8

2.1 ± 1.8

8.1 ± 0.8

22.3 ± 7.4

16.1 ± 0.6

178.6 ± 1.8

41.5 ± 1.0

54.5 ± 1.5

3.9 ± 0.5

 Treatment – Pre treatment

- 32.0

 + 38.0

- 4.3

 + 1.3

- 1.3

 + 22.3

 + 1.0

 + 2.8

- 21.8

 + 24.7

- 2.9

 P value

0.00006

0.0001

0.0107

0.1114

0.0511

0.0063

0.0638

0.4868

0.000005

0.00001

0.0055

Lbr

 Pre-treatment

98.5 ± 2.6

43.7 ± 1.9

13.8 ± 0.5

1.0 ± 0.1

9.6 ± 0.5

0.0 ± 0.0

17.9 ± 0.5

184.6 ± 5.9

63.1 ± 0.3

28.0 ± 0.3

8.8 ± 0.1

 Treatment

101.3 ± 0.9

36.3 ± 2.2

15.4 ± 1.7

1.0 ± 0.1

8.3 ± 0.3

0.0 ± 0.0

17.0 ± 0.7

179.8 ± 2.3

66.1 ± 0.2

23.7 ± 1.3

10.0 ± 1.2

 Treatment – Pre treatment

 + 2.8

- 7.3

 + 1.6

-

- 1.2

 

- 0.8

- 4.8

 + 3.0

 + 4.2

 + 1.2

 P value

0.1443

0.0124

0.1853

0.5772

0.0220

 

0.1619

0.2624

0.0002

0.0050

0.1422

Lbr-100G

 Pre-treatment

94.3 ± 3.7

46.3 ± 1.0

10.5 ± 2.4

3.3 ± 1.8

9.4 ± 0.8

0.0 ± 0.0

13.7 ± 2.5

177.7 ± 6.1

62.4 ± 1.9

30.6 ± 1.2

6.9 ± 1.5

 Treatment

69.6 ± 4.8

86.7 ± 5.2

5.4 ± 0.8

5.5 ± 1.2

6.4 ± 1.1

61.4 ± 10.7

14.6 ± 3.3

187.9 ± 5.4

43.0 ± 3.0

53.6 ± 3.2

3.3 ± 0.4

 Treatment – Pre treatment

- 24.0

 + 40.4

- 5.1

 + 2.3

- 3.1

 + 61.4

 + 0.5

 + 10.1

- 19.3

 + 22.9

- 3.6

 P value

0.0021

0.0001

0.0256

0.1529

0.0170

0.0047

0.8546

0.0986

0.0007

0.00032

0.0182

  1. Data are means ± SD for the last 3 days of each treatment period. Delta corresponds the difference between treatment and pre-treatment. P value is calculated for the pairwise comparison of the last 3 days of treatment and pre-treatment periods within a reactor by unpaired t-test. CR, Control reactor; 100G, 100 mM glycerol; Lbr, L. reuteri PTA5_F13; Lbr-100G, L. reuteri PTA5_F13 and 100 mM glycerol